World Health Organization W. Global incidence and prevalence of selected curable sexually transmitted infections. 2008. ISBN 978 92 4 150383 9
World Health O. Global prevalence and incidence of selected curable sexually transmitted infections: overviews and estimates. In: WHO/ HIV_AIDS. Edited by Organization WH. Geneva; 2001.
Miller WC, Swygard H, Hobbs MM, Ford CA, Handcock MS, Morris M, et al. The prevalence of trichomoniasis in young adults in the United States. Sex Transm Dis. 2005;32(10):593–8.
PubMed
Google Scholar
Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001–2004. Clin Infect Dis. 2007;45(10):1319–26.
PubMed
Google Scholar
Gregson S, Mason PR, Garnett GP, Zhuwau T, Nyamukapa CA, Anderson RM, et al. A rural HIV epidemic in Zimbabwe? Findings from a population-based survey. Int J STD AIDS. 2001;12(3):189–96.
CAS
PubMed
Google Scholar
Klinger EV, Kapiga SH, Sam NE, Aboud S, Chen CY, Ballard RC, et al. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis. 2006;33(12):712–8.
PubMed
Google Scholar
Mgone CS, Lupiwa T, Yeka W. High prevalence of Neisseria gonorrhoeae and multiple sexually transmitted diseases among rural women in the Eastern Highlands Province of Papua New Guinea, detected by polymerase chain reaction. Sex Transm Dis. 2002;29(12):775–9.
PubMed
Google Scholar
Wangnapi RA, Soso S, Unger HW, Sawera C, Ome M, Umbers AJ, et al. Prevalence and risk factors for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant women in Papua New Guinea. Sex Transm Infect. 2015;91(3):194–200.
CAS
PubMed
Google Scholar
Lan PT, Lundborg CS, Phuc HD, Sihavong A, Unemo M, Chuc NT, et al. Reproductive tract infections including sexually transmitted infections: a population-based study of women of reproductive age in a rural district of Vietnam. Sex Transm Infect. 2008;84(2):126–32.
CAS
PubMed
Google Scholar
Depuydt CE, Leuridan E, Van Damme P, Bogers J, Vereecken AJ, Donders GG. Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders. Gynecol Obstet Invest. 2010;70(4):273–80.
PubMed
Google Scholar
Huang HC, Yu SF, Cai M, Tan F, Zheng XY, Pan CW. Preparation of monoclonal antibodies against the adhesion protein 33 of Trichomonas vaginalis. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2007;25(2):97–100. 105.
PubMed
Google Scholar
Johnston VJ, Mabey DC. Global epidemiology and control of Trichomonas vaginalis. Curr Opin Infect Dis. 2008;21(1):56–64.
PubMed
Google Scholar
Paz-Bailey G, Morales-Miranda S, Jacobson JO, Gupta SK, Sabin K, Mendoza S, et al. High rates of STD and sexual risk behaviors among Garifunas in Honduras. J Acquir Immune Defic Syndr. 2009;51 Suppl 1:S26–34.
PubMed
Google Scholar
Miller WC, Zenilman JM. Epidemiology of chlamydial infection, gonorrhea, and trichomoniasis in the United States--2005. Infect Dis Clin North Am. 2005;19(2):281–96.
PubMed
Google Scholar
Shafir SC, Sorvillo FJ, Smith L. Current issues and considerations regarding trichomoniasis and human immunodeficiency virus in African-Americans. Clin Microbiol Rev. 2009;22(1):37–45. Table of Contents.
PubMed
PubMed Central
Google Scholar
Freeman AH, Katz KA, Pandori MW, Rauch LM, Kohn RP, Liska S, et al. Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay. Sex Transm Dis. 2010;37(3):165–8.
PubMed
Google Scholar
Rathod SD, Krupp K, Klausner JD, Arun A, Reingold AL, Madhivanan P. Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis. Sex Transm Dis. 2011;38(9):882–6.
PubMed
PubMed Central
Google Scholar
Harp DF, Chowdhury I. Trichomoniasis: evaluation to execution. Eur J Obstet Gynecol Reprod Biol. 2011;157(1):3–9.
PubMed
PubMed Central
Google Scholar
Carlton JM, Hirt RP, Silva JC, Delcher AL, Schatz M, Zhao Q, et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science. 2007;315(5809):207–12.
PubMed
PubMed Central
Google Scholar
Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin Microbiol Rev. 1998;11(2):300–17.
CAS
PubMed
PubMed Central
Google Scholar
Krieger JN. Trichomoniasis in men: old issues and new data. Sex Transm Dis. 1995;22(2):83–96.
CAS
PubMed
Google Scholar
Burch TA, Rees CW, Reardon L. Diagnosis of Trichomonas vaginalis vaginitis. Am J Obstet Gynecol. 1959;77(2):309–13.
CAS
PubMed
Google Scholar
Afzan MY, Suresh K. Pseudocyst forms of Trichomonas vaginalis from cervical neoplasia. Parasitol Res. 2012;111(1):371–81.
CAS
PubMed
Google Scholar
Pereira-Neves A, Ribeiro KC, Benchimol M. Pseudocysts in trichomonads--new insights. Protist. 2003;154(3–4):313–29.
PubMed
Google Scholar
Charles SX. Epidemiology of trichomonas vaginalis (TV) in rural adolescent and juvenile children. J Trop Pediatr. 1991;37(2):90.
CAS
PubMed
Google Scholar
Adu-Sarkodie Y. Trichomonas vaginalis transmission in a family. Genitourin Med. 1995;71(3):199–200.
CAS
PubMed
PubMed Central
Google Scholar
Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, Buve A. Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. PLoS One. 2011;6(1):e16310.
CAS
PubMed
PubMed Central
Google Scholar
Goodman RP, Freret TS, Kula T, Geller AM, Talkington MW, Tang-Fernandez V, et al. Clinical isolates of Trichomonas vaginalis concurrently infected by strains of up to four Trichomonasvirus species (Family Totiviridae). J Virol. 2011;85(9):4258–70.
CAS
PubMed
PubMed Central
Google Scholar
Sena AC, Miller WC, Hobbs MM, Schwebke JR, Leone PA, Swygard H, et al. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention. Clin Infect Dis. 2007;44(1):13–22.
PubMed
Google Scholar
Wolner-Hanssen P, Krieger JN, Stevens CE, Kiviat NB, Koutsky L, Critchlow C, et al. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989;261(4):571–6.
CAS
PubMed
Google Scholar
Martinez-Garcia F, Regadera J, Mayer R, Sanchez S, Nistal M. Protozoan infections in the male genital tract. J Urol. 1996;156(2 Pt 1):340–9.
CAS
PubMed
Google Scholar
Allsworth JE, Ratner JA, Peipert JF. Trichomoniasis and other sexually transmitted infections: results from the 2001–2004 National Health and Nutrition Examination Surveys. Sex Transm Dis. 2009;36(12):738–44.
PubMed
PubMed Central
Google Scholar
Silver BJ, Guy RJ, Kaldor JM, Jamil MS, Rumbold AR. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014;41(6):369–76.
PubMed
Google Scholar
Mann JR, McDermott S, Barnes TL, Hardin J, Bao H, Zhou L. Trichomoniasis in pregnancy and mental retardation in children. Ann Epidemiol. 2009;19(12):891–9.
PubMed
Google Scholar
Schwandt A, Williams C, Beigi RH. Perinatal transmission of Trichomonas vaginalis: a case report. J Reprod Med. 2008;53(1):59–61.
PubMed
Google Scholar
Carter JE, Whithaus KC. Neonatal respiratory tract involvement by Trichomonas vaginalis: a case report and review of the literature. Am J Trop Med Hyg. 2008;78(1):17–9.
PubMed
Google Scholar
Temesvari P, Kerekes A, Tege A, Szarka K. Demonstration of Trichomonas vaginalis in tracheal aspirates in infants with early respiratory failure. J Matern Fetal Neonatal Med. 2002;11(5):347–9.
CAS
PubMed
Google Scholar
Kissinger P, Adamski A. Trichomoniasis and HIV interactions: a review. Sex Transm Infect. 2013;89(6):426–33.
PubMed
PubMed Central
Google Scholar
Sardana S, Sodhani P, Agarwal SS, Sehgal A, Roy M, Singh V, et al. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol. 1994;38(5):693–7.
CAS
PubMed
Google Scholar
Guenthner PC, Secor WE, Dezzutti CS. Trichomonas vaginalis-induced epithelial monolayer disruption and human immunodeficiency virus type 1 (HIV-1) replication: implications for the sexual transmission of HIV-1. Infect Immun. 2005;73(7):4155–60.
CAS
PubMed
PubMed Central
Google Scholar
Moodley P, Connolly C, Sturm AW. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. J Infect Dis. 2002;185(1):69–73.
PubMed
Google Scholar
van de Wijgert JH, Morrison CS, Brown J, Kwok C, Van Der Pol B, Chipato T, et al. Disentangling contributions of reproductive tract infections to HIV acquisition in African Women. Sex Transm Dis. 2009;36(6):357–64.
PubMed
Google Scholar
Sorvillo F, Kerndt P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet. 1998;351(9097):213–4.
CAS
PubMed
Google Scholar
Chesson HW, Blandford JM, Pinkerton SD. Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States. Sex Transm Dis. 2004;31(9):547–51.
PubMed
Google Scholar
McClelland RS. Trichomonas vaginalis infection: can we afford to do nothing? J Infect Dis. 2008;197(4):487–9.
PubMed
PubMed Central
Google Scholar
Price MA, Stewart SR, Miller WC, Behets F, Dow WH, Martinson FE, et al. The cost-effectiveness of treating male trichomoniasis to avert HIV transmission in men seeking sexually transmitted disease care in Malawi. J Acquir Immune Defic Syndr. 2006;43(2):202–9.
PubMed
Google Scholar
Sorvillo F, Smith L, Kerndt P, Ash L. Trichomonas vaginalis, HIV, and African-Americans. Emerg Infect Dis. 2001;7(6):927–32.
CAS
PubMed
PubMed Central
Google Scholar
Price MA, Zimba D, Hoffman IF, Kaydos-Daniels SC, Miller WC, Martinson F, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis. 2003;30(6):516–22.
CAS
PubMed
Google Scholar
Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis. 2001;183(7):1017–22.
CAS
PubMed
Google Scholar
Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, et al. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009;36(1):11–6.
PubMed
PubMed Central
Google Scholar
Boselli F, Chiossi G, Bortolamasi M, Gallinelli A. Prevalence and determinants of genital shedding of herpes simplex virus among women attending Italian colposcopy clinics. Eur J Obstet Gynecol Reprod Biol. 2005;118(1):86–90.
PubMed
Google Scholar
Gottlieb SL, Douglas Jr JM, Foster M, Schmid DS, Newman DR, Baron AE, et al. Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis. 2004;190(6):1059–67.
PubMed
Google Scholar
Zhang ZF, Begg CB. Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidemiol. 1994;23(4):682–90.
CAS
PubMed
Google Scholar
Viikki M, Pukkala E, Nieminen P, Hakama M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 2000;39(1):71–5.
CAS
PubMed
Google Scholar
Roeters AM, Boon ME, van Haaften M, Vernooij F, Bontekoe TR, Heintz AP. Inflammatory events as detected in cervical smears and squamous intraepithelial lesions. Diagn Cytopathol. 2010;38(2):85–93.
PubMed
Google Scholar
Li CD, Zhang WY, Wu MH, Zhang SW, Zhou BL, Zhu L, et al. Analysis of high risk factors associated with cervical intraepithelial neoplasia in married women aged 25–54 years in Beijing between 2007–2008. Zhonghua Fu Chan Ke Za Zhi. 2010;45(10):757–61.
CAS
PubMed
Google Scholar
Yap EH, Ho TH, Chan YC, Thong TW, Ng GC, Ho LC, et al. Serum antibodies to Trichomonas vaginalis in invasive cervical cancer patients. Genitourin Med. 1995;71(6):402–4.
CAS
PubMed
PubMed Central
Google Scholar
Sutcliffe S, Alderete JF, Till C, Goodman PJ, Hsing AW, Zenilman JM, et al. Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. Int J Cancer. 2009;124(9):2082–7.
CAS
PubMed
PubMed Central
Google Scholar
Sutcliffe S, Giovannucci E, Alderete JF, Chang TH, Gaydos CA, Zenilman JM, et al. Plasma antibodies against Trichomonas vaginalis and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2006;15(5):939–45.
CAS
PubMed
Google Scholar
Kingston MA, Bansal D, Carlin EM. ‘Shelf life’ of trichomonas vaginalis. Int J STD AIDS. 2003;14(1):28–9.
CAS
PubMed
Google Scholar
Peterman TA, Tian LH, Metcalf CA, Malotte CK, Paul SM, Douglas Jr JM, et al. Persistent, undetected Trichomonas vaginalis infections? Clin Infect Dis. 2009;48(2):259–60.
PubMed
Google Scholar
Gatski M, Mena L, Levison J, Clark RA, Henderson H, Schmidt N, et al. Patient-delivered partner treatment and Trichomonas vaginalis repeat infection among human immunodeficiency virus-infected women. Sex Transm Dis. 2010;37(8):502–5.
CAS
PubMed
PubMed Central
Google Scholar
Nye MB, Schwebke JR, Body BA. Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women. Am J Obstet Gynecol. 2009;200(2):188. e181-187.
PubMed
Google Scholar
Huppert JS, Biro F, Lan D, Mortensen JE, Reed J, Slap GB. Urinary symptoms in adolescent females: STI or UTI? J Adolesc Health. 2007;40(5):418–24.
PubMed
PubMed Central
Google Scholar
Andrea SB, Chapin KC. Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications. J Clin Microbiol. 2011;49(3):866–9.
PubMed
PubMed Central
Google Scholar
Van Der Pol B, Kraft CS, Williams JA. Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens. J Clin Microbiol. 2006;44(2):366–73.
Google Scholar
Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, Miller WC, et al. Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis. 2007;45(2):194–8.
CAS
PubMed
Google Scholar
Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women. J Infect Dis. 2005;192(12):2039–44.
Google Scholar
Williams JA, Ofner S, Batteiger BE, Fortenberry JD, Van Der Pol B. Duration of polymerase chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis infections in women. Sex Transm Dis. 2014;41(3):215–9.
CAS
PubMed
Google Scholar
Wendel KA, Workowski KA. Trichomoniasis: challenges to appropriate management. Clin Infect Dis. 2007;44 Suppl 3:S123–129.
PubMed
Google Scholar
Cudmore SL, Garber GE. Prevention or treatment: the benefits of Trichomonas vaginalis vaccine. J Infect Public Health. 2010;3(2):47–53.
PubMed
Google Scholar
Burtin P, Taddio A, Ariburnu O, Einarson TR, Koren G. Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol. 1995;172(2 Pt 1):525–9.
CAS
PubMed
Google Scholar
Caro-Paton T, Carvajal A, Martin de Diego I, Martin-Arias LH, Alvarez Requejo A, Rodriguez Pinilla E. Is metronidazole teratogenic? A meta-analysis. Br J Clin Pharmacol. 1997;44(2):179–82.
CAS
PubMed
PubMed Central
Google Scholar
Workowski KA, Berman S, Centers for Disease C, Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommend Rep. 2010;59(RR-12):1–110.
Google Scholar
Helms DJ, Mosure DJ, Secor WE, Workowski KA. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity. Am J Obstet Gynecol. 2008;198(4):370. e371-377.
PubMed
Google Scholar
Chen MY, Smith NA, Fox EF, Bingham JS, Barlow D. Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis. Int J STD AIDS. 1999;10(4):277–80.
CAS
PubMed
Google Scholar
Muzny C, Barnes A, Mena L. Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid. Sex Health. 2012;9(4):389–91.
PubMed
Google Scholar
Goldman LM, Upcroft JA, Workowski K, Rapkin A. Treatment of metronidazole-resistant Trichomonas vaginalis. Sex Health. 2009;6(4):345–7.
PubMed
Google Scholar
Nyirjesy P, Gilbert J, Mulcahy LJ. Resistant trichomoniasis: successful treatment with combination therapy. Sex Transm Dis. 2011;38(10):962–3.
PubMed
Google Scholar
Dan M, Sobel JD. Failure of nitazoxanide to cure trichomoniasis in three women. Sex Transm Dis. 2007;34(10):813–4.
PubMed
Google Scholar
Mammen-Tobin A, Wilson JD. Management of metronidazole-resistant Trichomonas vaginalis--a new approach. Int J STD AIDS. 2005;16(7):488–90.
CAS
PubMed
Google Scholar
Vieira Pde B, Giordani RB, Macedo AJ, Tasca T. Natural and synthetic compound anti-Trichomonas vaginalis: an update review. Parasitol Res. 2015;114(4):1249–61.
PubMed
Google Scholar
Kissinger P, Hogben M. Expedited partner treatment for sexually transmitted infections: an update. Curr Infect Dis Rep. 2011;13(2):188–95.
PubMed
Google Scholar
Gatski M, Martin DH, Levison J, Mena L, Clark RA, Murphy M, et al. The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women. Sex Transm Infect. 2011;87(3):205–8.
PubMed
PubMed Central
Google Scholar
Adamski A, Clark RA, Mena L, Henderson H, Levison J, Schmidt N, et al. The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women. Clin Infect Dis. 2014;59(6):883–7.
CAS
PubMed
PubMed Central
Google Scholar
Balkus JE, Richardson BA, Mochache V, Chohan V, Chan JD, Masese L, et al. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women. Sex Transm Dis. 2013;40(6):499–505.
CAS
PubMed
PubMed Central
Google Scholar
Lazenby GB, Unal ER, Andrews AL, Simpson K. Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014;41(6):353–8.
PubMed
Google Scholar
Kissinger P, Secor WE, Leichliter JS, Clark RA, Schmidt N, Curtin E, et al. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis. 2008;46(7):994–9.
PubMed
Google Scholar
Krashin JW, Koumans EH, Bradshaw-Sydnor AC, Braxton JR, Evan Secor W, Sawyer MK, et al. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sex Transm Dis. 2010;37(7):440–4.
PubMed
Google Scholar
Kissinger P, Schmidt N, Mohammed H, Leichliter JS, Gift TL, Meadors B, et al. Patient-delivered partner treatment for Trichomonas vaginalis infection: a randomized controlled trial. Sex Transm Dis. 2006;33(7):445–50.
PubMed
Google Scholar
Spence MR, Harwell TS, Davies MC, Smith JL. The minimum single oral metronidazole dose for treating trichomoniasis: a randomized, blinded study. Obstet Gynecol. 1997;89(5 Pt 1):699–703.
CAS
PubMed
Google Scholar
Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev. 2003;2:CD000218.
PubMed
Google Scholar
Csonka GW. Trichomonal vaginitis treated with one dose of metronidazole. Br J Vener Dis. 1971;47(6):456–8.
CAS
PubMed
PubMed Central
Google Scholar
Hager WD, Brown ST, Kraus SJ, Kleris GS, Perkins GJ, Henderson M. Metronidazole for vaginal trichomoniasis. Seven-day vs single-dose regimens. JAMA. 1980;244(11):1219–20.
CAS
PubMed
Google Scholar
Schwebke JR, Barrientes FJ. Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole. Antimicrob Agents Chemother. 2006;50(12):4209–10.
CAS
PubMed
PubMed Central
Google Scholar
Perez S, Fernandez-Verdugo A, Perez F, Vazquez F. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain. Sex Transm Dis. 2001;28(2):115–6.
CAS
PubMed
Google Scholar
Schmid G, Narcisi E, Mosure D, Secor WE, Higgins J, Moreno H. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic. J Reprod Med. 2001;46(6):545–9.
CAS
PubMed
Google Scholar
Magnus M, Clark R, Myers L, Farley T, Kissinger PJ. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis. 2003;30(11):839–43.
CAS
PubMed
Google Scholar
Niccolai LM, Kopicko JJ, Kassie A, Petros H, Clark RA, Kissinger P. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis. 2000;27(5):284–8.
CAS
PubMed
Google Scholar
Lyng J, Christensen J. A double-blind study of the value of treatment with a single dose tinidazole of partners to females with trichomoniasis. Acta Obstet Gynecol Scand. 1981;60(2):199–201.
CAS
PubMed
Google Scholar
Schwebke JR, Desmond RA. A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women. Sex Transm Dis. 2010;37(6):392–6.
PubMed
Google Scholar
Hirt RP, Sherrard J. Trichomonas vaginalis origins, molecular pathobiology and clinical considerations. Curr Opin Infect Dis. 2015;28(1):72–9.
CAS
PubMed
Google Scholar
Martin DH, Zozaya M, Lillis RA, Myers L, Nsuami MJ, Ferris MJ. Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. J Infect Dis. 2013;207(12):1922–31.
PubMed
PubMed Central
Google Scholar
Kissinger P, Mena L, Levison J, Clark RA, Gatski M, Henderson H, et al. A randomized treatment trial: single versus 7 day dose of metronidazole for the treatment of trichomonas vaginalis among hiv-infected women. J Acquir Immune Defic Syndr. 2011;55(5):565–71.
Google Scholar
Warren D, Klein RS, Sobel J, Kieke Jr B, Brown W, Schuman P, et al. A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynecol. 2001;9(3):133–41.
CAS
PubMed
PubMed Central
Google Scholar
Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE. Prevalence and correlates of chlamydia trachomatis, neisseria gonorrhoeae, trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis. 2005;32(7):446–53.
PubMed
Google Scholar
Taha TE, Hoover DR, Dallabetta GA, Kumwenda NI, Mtimavalye LA, Yang LP, et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS. 1998;12(13):1699–706.
CAS
PubMed
Google Scholar
Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, Wabwire-Mangen F, et al. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet. 1997;350(9077):546–50.
CAS
PubMed
Google Scholar
Thomason JL, Gelbart SM, Sobun JF, Schulien MB, Hamilton PR. Comparison of four methods to detect Trichomonas vaginalis. J Clin Microbiol. 1988;26(9):1869–70.
CAS
PubMed
PubMed Central
Google Scholar
Franklin TL, Monif GR. Trichomonas vaginalis and bacterial vaginosis. Coexistence in vaginal wet mount preparations from pregnant women. J Reprod Med. 2000;45(2):131–4.
CAS
PubMed
Google Scholar
Demirezen S, Kaya D, Beksac S. Cytologic findings in pap smears with Actinomyces-like organisms. Acta Cytol. 2005;49(3):257–61.
PubMed
Google Scholar
Heller DS, Maslyak S, Skurnick J. Is the presence of Trichomonas on a Pap smear associated with an increased incidence of bacterial vaginosis? J Low Genit Tract Dis. 2006;10(3):137–9.
PubMed
Google Scholar
Fettweis JM, Serrano MG, Huang B, Brooks JP, Glascock AL, Sheth NU, et al. An emerging mycoplasma associated with trichomoniasis, vaginal infection and disease. PLoS One. 2014;9(10):e110943.
PubMed
PubMed Central
Google Scholar
Brotman RM, Bradford LL, Conrad M, Gajer P, Ault K, Peralta L, et al. Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women. Sex Transm Dis. 2012;39(10):807–12.
PubMed
PubMed Central
Google Scholar
Hillier SL, Krohn MA, Nugent RP, Gibbs RS. Characteristics of three vaginal flora patterns assessed by gram stain among pregnant women. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol. 1992;166(3):938–44.
CAS
PubMed
Google Scholar